Your browser doesn't support javascript.
loading
Rapid and sustained control of itch and reduction in Th2 bias by dupilumab in a patient with Sézary syndrome.
Steck, O; Bertschi, N L; Luther, F; van den Berg, J; Winkel, D J; Holbro, A; Schlapbach, C.
Affiliation
  • Steck O; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Bertschi NL; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Luther F; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • van den Berg J; Department of Hematology, University Hospital Basel, Basel, Switzerland.
  • Winkel DJ; Blood Transfusion Center, Swiss Red Cross, Basel, Switzerland.
  • Holbro A; Radiology & Nuclear Medicine Clinic, University Hospital Basel, Basel, Switzerland.
  • Schlapbach C; Department of Hematology, University Hospital Basel, Basel, Switzerland.
J Eur Acad Dermatol Venereol ; 35(6): 1331-1337, 2021 Jun.
Article in En | MEDLINE | ID: mdl-33068311
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Sezary Syndrome Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2021 Document type: Article Affiliation country: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Sezary Syndrome Type of study: Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2021 Document type: Article Affiliation country: Switzerland